Literature DB >> 20209567

Analysis of buserelin in urine by online combination of capillary zone electrophoresis with electrospray mass spectrometry.

Andrea Staňová1, Jozef Marák1, Vítězslav Maier2, Václav Ranc2, Joanna Znaleziona2, Juraj Ševčík2, Dušan Kaniansky1.   

Abstract

A fast and precise analysis of the synthetic peptide buserelin in urine using CZE-ESI-MS method has been demonstrated. Formic acid at 50 mmol/L concentration served as background electrolyte in CZE stage and it is compatible with MS detection in positive ionization mode. Two injection modes were tested, i.e. pressure (50 mbar for 5 s) and electrokinetic injection (5 kV for 5 s), of which electrokinetic injection provided better calibration parameters. Buserelin LODs were 0.47 microg/mL in water and 0.63 microg/mL in ten times diluted urine samples using pressure injection, while they were 0.32 microg/mL in water and 0.34 microg/mL in ten times diluted urine samples using electrokinetic injection. Repeatability of buserelin migration times was below 6% (pressure injection mode) and 1% (electrokinetic injection mode). Repeatability of buserelin peak area in SIM mode (m/z=620.5+/-0.5) was less than 12% (pressure injection mode) and 5.8% (electrokinetic injection mode). In this work, no interferences were observed during the analyses of spiked urine samples.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209567     DOI: 10.1002/elps.200900422

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.595


  2 in total

1.  A stability indicating capillary electrophoresis method for analysis of buserelin.

Authors:  Elnaz Tamizi; Ernst Kenndler; Abolghasem Jouyban
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

2.  The pharmacokinetics of buserelin after intramuscular administration in pigs and cows.

Authors:  Jingyuan Kong; Fuqin Su; Yu Liu; Yuxin Yang; Yuying Cao; Jicheng Qiu; Yue Wang; Lu Zhang; Jianzhong Wang; Xingyuan Cao
Journal:  BMC Vet Res       Date:  2022-04-11       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.